Breast cancer survivors have an increased risk of developing contralateral breast cancer (CBC), with approximately 1 in 30 developing CBC within 10 years of their initial diagnosis. However, few U.S. studies have examined CBC risk by racial and ethnic differences or by estrogen receptor (ER) subtype of the contra...
Michelle O. Sodipo, J. Vo, J. Shing et al.· Cancer Epidemiology, Biomark...· 0 citations
Cardiovascular disease (CVD) is a leading cause of morbidity and non-cancer mortality among U.S. breast cancer survivors. Differences in risk factors and receipt of cardiotoxic cancer treatment may contribute to disproportionate cardiovascular outcomes by race and ethnicity. This scoping review comprehensively ev...
Isha Patel, L. Brock, Yue-Han Wang et al.· Cancer Epidemiology, Biomark...· 0 citations
A comprehensive analysis of 60 CIMs provides limited evidence supporting broad causal effects of circulating inflammatory markers contributing to variation in MD phenotypes, although most instruments demonstrated weak conditional instrument strength after inclusion of BMI.
A. H. Suger, T. Harrison, C. Haas et al.· medRxiv· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.